BiotechTube
Home/Senseera/Prof. Nir Friedman
PN

Prof. Nir Friedman

CSO

Senseera

Therapeutic Areas

HepatologyOncologyTransplantImmunologyMetabolic Disease

Senseera Pipeline

DrugIndicationPhase
Liver Transplant Rejection AssayAcute cellular rejectionClinical POC
MASH Biomarker PanelNon‑alcoholic steatohepatitisClinical POC
HCC Diagnostic TestHepatocellular carcinomaClinical POC

Leadership Team at Senseera

DR
Dr. Ronen Sadeh
CEO
DJ
Dr. Jenia Gutin
CTO
DI
Dr. Israa Sharkia
VP R&D
DB
Daniella Beller
COO & Head of Business Development
View full Senseera profile